Cargando…
Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development
Non-alcoholic fatty liver disease (NAFLD) is a complex disorder characterized by the accumulation of fat in the liver in the absence of excessive alcohol consumption. It is one of the most common liver diseases worldwide, affecting approximately 25% of the global population. It is closely associated...
Autores principales: | Jin, Yujin, Heo, Kyung-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316197/ https://www.ncbi.nlm.nih.gov/pubmed/37386828 http://dx.doi.org/10.4196/kjpp.2023.27.4.299 |
Ejemplares similares
-
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
por: Xu, Xiaohan, et al.
Publicado: (2022) -
The immune response as a therapeutic target in non-alcoholic fatty liver disease
por: Ortiz-López, Nicolás, et al.
Publicado: (2022) -
Experimental models of metabolic and alcoholic fatty liver disease
por: Buyco, Delfin Gerard, et al.
Publicado: (2021) -
Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets
por: Blas-García, Ana, et al.
Publicado: (2022) -
Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
por: Tanase, Daniela Maria, et al.
Publicado: (2021)